Creekside Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Hold
3,941
0.11% 155
2026
Q1
$341K Hold
3,941
0.14% 136
2025
Q4
$379K Hold
3,941
0.16% 124
2025
Q3
$375K Hold
3,941
0.17% 122
2025
Q2
$344K Hold
3,941
0.16% 128
2025
Q1
$354K Hold
3,941
0.19% 120
2024
Q4
$315K Hold
3,941
0.16% 127
2024
Q3
$355K Buy
+3,941
New +$332K 0.18% 123

Other funds holding MDT

Creekside Partners's MDT Position: Q2 2026 in Review

Creekside Partners held its Medtronic (MDT) position steady in Q2 2026 at 3,941 shares worth $308K. The position accounts for 0.11% of the portfolio, ranked #155.

Creekside Partners first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $379K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Creekside Partners held 3,941 shares of Medtronic worth $308K as of Q2 2026.
  • Creekside Partners left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.11% of Creekside Partners's portfolio in Q2 2026, its #155 holding.
  • Creekside Partners first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Creekside Partners's Medtronic position peaked at $379K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Creekside Partners's 13F filing for Q2 2026, filed 31 Jul 2026.